The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Point of Care Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Assays and Kits
1.2.3 Instruments and Analyzers
1.2.4 Software and Services
1.2.5 Others
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Point of Care Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Tumor
1.3.3 Hematology
1.3.4 Endocrinology
1.3.5 Infectious Disease
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Point of Care Market Perspective (2018-2029)
2.2 Molecular Diagnostics Point of Care Growth Trends by Region
2.2.1 Global Molecular Diagnostics Point of Care Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Molecular Diagnostics Point of Care Historic Market Size by Region (2018-2023)
2.2.3 Molecular Diagnostics Point of Care Forecasted Market Size by Region (2024-2029)
2.3 Molecular Diagnostics Point of Care Market Dynamics
2.3.1 Molecular Diagnostics Point of Care Industry Trends
2.3.2 Molecular Diagnostics Point of Care Market Drivers
2.3.3 Molecular Diagnostics Point of Care Market Challenges
2.3.4 Molecular Diagnostics Point of Care Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Point of Care Players by Revenue
3.1.1 Global Top Molecular Diagnostics Point of Care Players by Revenue (2018-2023)
3.1.2 Global Molecular Diagnostics Point of Care Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Diagnostics Point of Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics Point of Care Revenue
3.4 Global Molecular Diagnostics Point of Care Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Point of Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Point of Care Revenue in 2022
3.5 Molecular Diagnostics Point of Care Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics Point of Care Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics Point of Care Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Point of Care Breakdown Data by Type
4.1 Global Molecular Diagnostics Point of Care Historic Market Size by Type (2018-2023)
4.2 Global Molecular Diagnostics Point of Care Forecasted Market Size by Type (2024-2029)
5 Molecular Diagnostics Point of Care Breakdown Data by Application
5.1 Global Molecular Diagnostics Point of Care Historic Market Size by Application (2018-2023)
5.2 Global Molecular Diagnostics Point of Care Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Molecular Diagnostics Point of Care Market Size (2018-2029)
6.2 North America Molecular Diagnostics Point of Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Molecular Diagnostics Point of Care Market Size by Country (2018-2023)
6.4 North America Molecular Diagnostics Point of Care Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnostics Point of Care Market Size (2018-2029)
7.2 Europe Molecular Diagnostics Point of Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Molecular Diagnostics Point of Care Market Size by Country (2018-2023)
7.4 Europe Molecular Diagnostics Point of Care Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Point of Care Market Size (2018-2029)
8.2 Asia-Pacific Molecular Diagnostics Point of Care Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Molecular Diagnostics Point of Care Market Size by Region (2018-2023)
8.4 Asia-Pacific Molecular Diagnostics Point of Care Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Point of Care Market Size (2018-2029)
9.2 Latin America Molecular Diagnostics Point of Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Molecular Diagnostics Point of Care Market Size by Country (2018-2023)
9.4 Latin America Molecular Diagnostics Point of Care Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Point of Care Market Size (2018-2029)
10.2 Middle East & Africa Molecular Diagnostics Point of Care Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Molecular Diagnostics Point of Care Market Size by Country (2018-2023)
10.4 Middle East & Africa Molecular Diagnostics Point of Care Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Diagnostics Point of Care Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Abaxis
11.2.1 Abaxis Company Detail
11.2.2 Abaxis Business Overview
11.2.3 Abaxis Molecular Diagnostics Point of Care Introduction
11.2.4 Abaxis Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.2.5 Abaxis Recent Development
11.3 Bayer Healthcare
11.3.1 Bayer Healthcare Company Detail
11.3.2 Bayer Healthcare Business Overview
11.3.3 Bayer Healthcare Molecular Diagnostics Point of Care Introduction
11.3.4 Bayer Healthcare Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.3.5 Bayer Healthcare Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Detail
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Molecular Diagnostics Point of Care Introduction
11.4.4 Bio-Rad Laboratories Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Becton Dickinson and Company
11.5.1 Becton Dickinson and Company Company Detail
11.5.2 Becton Dickinson and Company Business Overview
11.5.3 Becton Dickinson and Company Molecular Diagnostics Point of Care Introduction
11.5.4 Becton Dickinson and Company Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.5.5 Becton Dickinson and Company Recent Development
11.6 Binx Health
11.6.1 Binx Health Company Detail
11.6.2 Binx Health Business Overview
11.6.3 Binx Health Molecular Diagnostics Point of Care Introduction
11.6.4 Binx Health Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.6.5 Binx Health Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Detail
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Molecular Diagnostics Point of Care Introduction
11.7.4 BioMerieux Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.7.5 BioMerieux Recent Development
11.8 Co-Diagnostics
11.8.1 Co-Diagnostics Company Detail
11.8.2 Co-Diagnostics Business Overview
11.8.3 Co-Diagnostics Molecular Diagnostics Point of Care Introduction
11.8.4 Co-Diagnostics Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.8.5 Co-Diagnostics Recent Development
11.9 DanaherCorporation
11.9.1 DanaherCorporation Company Detail
11.9.2 DanaherCorporation Business Overview
11.9.3 DanaherCorporation Molecular Diagnostics Point of Care Introduction
11.9.4 DanaherCorporation Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.9.5 DanaherCorporation Recent Development
11.10 Dako
11.10.1 Dako Company Detail
11.10.2 Dako Business Overview
11.10.3 Dako Molecular Diagnostics Point of Care Introduction
11.10.4 Dako Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.10.5 Dako Recent Development
11.11 F. Hoffmann
11.11.1 F. Hoffmann Company Detail
11.11.2 F. Hoffmann Business Overview
11.11.3 F. Hoffmann Molecular Diagnostics Point of Care Introduction
11.11.4 F. Hoffmann Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.11.5 F. Hoffmann Recent Development
11.12 OraSure Technologies
11.12.1 OraSure Technologies Company Detail
11.12.2 OraSure Technologies Business Overview
11.12.3 OraSure Technologies Molecular Diagnostics Point of Care Introduction
11.12.4 OraSure Technologies Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.12.5 OraSure Technologies Recent Development
11.13 Roche Diagnostics
11.13.1 Roche Diagnostics Company Detail
11.13.2 Roche Diagnostics Business Overview
11.13.3 Roche Diagnostics Molecular Diagnostics Point of Care Introduction
11.13.4 Roche Diagnostics Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.13.5 Roche Diagnostics Recent Development
11.14 Nipro Diagnostics
11.14.1 Nipro Diagnostics Company Detail
11.14.2 Nipro Diagnostics Business Overview
11.14.3 Nipro Diagnostics Molecular Diagnostics Point of Care Introduction
11.14.4 Nipro Diagnostics Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.14.5 Nipro Diagnostics Recent Development
11.15 Genestat
11.15.1 Genestat Company Detail
11.15.2 Genestat Business Overview
11.15.3 Genestat Molecular Diagnostics Point of Care Introduction
11.15.4 Genestat Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.15.5 Genestat Recent Development
11.16 Meridian Bioscience
11.16.1 Meridian Bioscience Company Detail
11.16.2 Meridian Bioscience Business Overview
11.16.3 Meridian Bioscience Molecular Diagnostics Point of Care Introduction
11.16.4 Meridian Bioscience Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.16.5 Meridian Bioscience Recent Development
11.17 Molbio Diagnostics
11.17.1 Molbio Diagnostics Company Detail
11.17.2 Molbio Diagnostics Business Overview
11.17.3 Molbio Diagnostics Molecular Diagnostics Point of Care Introduction
11.17.4 Molbio Diagnostics Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.17.5 Molbio Diagnostics Recent Development
11.18 Siemens Healthcare
11.18.1 Siemens Healthcare Company Detail
11.18.2 Siemens Healthcare Business Overview
11.18.3 Siemens Healthcare Molecular Diagnostics Point of Care Introduction
11.18.4 Siemens Healthcare Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.18.5 Siemens Healthcare Recent Development
11.19 Thermo Fisher Scientific
11.19.1 Thermo Fisher Scientific Company Detail
11.19.2 Thermo Fisher Scientific Business Overview
11.19.3 Thermo Fisher Scientific Molecular Diagnostics Point of Care Introduction
11.19.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.19.5 Thermo Fisher Scientific Recent Development
11.20 Visby Medical
11.20.1 Visby Medical Company Detail
11.20.2 Visby Medical Business Overview
11.20.3 Visby Medical Molecular Diagnostics Point of Care Introduction
11.20.4 Visby Medical Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.20.5 Visby Medical Recent Development
11.21 Wuhan Easy Diagnosis Biomedicine
11.21.1 Wuhan Easy Diagnosis Biomedicine Company Detail
11.21.2 Wuhan Easy Diagnosis Biomedicine Business Overview
11.21.3 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Introduction
11.21.4 Wuhan Easy Diagnosis Biomedicine Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.21.5 Wuhan Easy Diagnosis Biomedicine Recent Development
11.22 Beijing Tiandz
11.22.1 Beijing Tiandz Company Detail
11.22.2 Beijing Tiandz Business Overview
11.22.3 Beijing Tiandz Molecular Diagnostics Point of Care Introduction
11.22.4 Beijing Tiandz Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.22.5 Beijing Tiandz Recent Development
11.23 Beijing Content
11.23.1 Beijing Content Company Detail
11.23.2 Beijing Content Business Overview
11.23.3 Beijing Content Molecular Diagnostics Point of Care Introduction
11.23.4 Beijing Content Revenue in Molecular Diagnostics Point of Care Business (2018-2023)
11.23.5 Beijing Content Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details